Navigation Links
PRA International Appoints Shannon as CEO

RALEIGH, N.C., Dec. 14 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, is pleased to announce that Colin Shannon, who has served as President and Chief Operating Officer of PRA since May 2007, has been appointed President, Chief Executive Officer (CEO) and Director, effective Jan. 1, 2010.

"It is with great pleasure that we welcome Colin to this top executive role," said Chairman of the Board, Melvin D. Booth. "Having worked closely with Colin for the last two and one-half years, it is clear that he is the ideal person to lead our Company. This planned transition ensures that PRA will maintain its momentum in driving 'evidence-based decision making' into clinical development and its continued focus on building a talent pool of clinical professionals." Jean-Pierre L. Conte, Chairman and Managing Director of Genstar Capital, LLC, the principal investor in PRA, further commented, "Colin has brought to PRA a depth of industry knowledge and a leadership style that fits well with our culture. We are confident PRA will continue to flourish under his leadership."

Prior to joining PRA, Mr. Shannon was employed by Pharmaceutical Product Development, Inc. (PPD) for twelve years in key executive positions, the last being Executive Vice President, Global Clinical Operations. Before joining PPD, Mr. Shannon held financial positions with various other companies. He holds a master's degree in business administration from London's City University and is a Fellow Member of the Chartered Association of Certified Accountants.

"I always had a deep respect for the PRA organization and its reputation within the industry," said Mr. Shannon. "Since joining PRA, the executive team has focused on developing our current mission and vision. As a result, my respect for PRA has deepened even more. I am truly impressed with the quality and commitment of the entire PRA team. Working together, we will build a global legacy of quality and trust."

"Much of the credit for this well-orchestrated transition goes to Terry Bieker," said Mr. Booth. "Three years ago Terry joined PRA, initially as a Director and Interim CEO, and a few months later as CEO. Thanks to Terry's leadership, we have aggressively grown our business globally by recruiting top talent, executing an innovative strategy, providing visionary leadership and committing to excellent service to our clients and respect for our employees." Mr. Conte added, "Terry is someone we know well as Genstar worked with him in a previous successful investment. We are very pleased with his leadership and the growth initiatives implemented under his tenure and, while we will miss him, we look forward to his continued counsel as a member of the PRA Board of Directors. "

"It has been an honor to serve as CEO," said Mr. Bieker. "I have enjoyed working with the many dedicated, professional people at PRA and I look forward to remaining an active board member. Retiring was a difficult choice to make, but I feel confident in knowing that Colin will be at the helm and will continue to lead PRA along the road to success."

About PRA International

PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and its differentiating PERSONAL ELEMENT enable its project teams to deliver consistent and on-time performance for clients.

This unique PRA philosophy--THE PERSONAL ELEMENT--recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development life cycle. To learn more about PRA International, please visit, email or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nonprofit Partners With PR Company and Gains International Attention
2. Medical Travel Quality Alliance to Certify Medical Tourism Agents for Safer, Quality Health Care for Traveling International Patients
3. Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange
4. Oncologist at the Childrens Hospital of Philadelphia to Chair International Childhood Cancer Organization
5. Reliv International Hires Director of Strategic Development
6. BridgeGate International Announces New Integration and Interoperability Training Program
7. AVIVA's Private Health Insurance Products Solutions Go International
8. Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference
9. Northern California Cancer Centers Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research
10. Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board
11. The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH
Post Your Comments:
(Date:11/30/2015)... ... 2015 , ... Holcomb – Kreithen Plastic Surgery and ... in Florida, is proud to announce that Dr. Joshua Kreithen, one of its ... a Johnson & Johnson Company. , Ethicon is a global medical device company ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. 8 virtual ... Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. Leaders from ...
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today that they are showcasing ... dentists to make complex business decisions by providing the tools and information they need ... survey with 10 procedures customized by zip code. , The Sikka Software Ecosystem ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of ... company. Because it is so important to this key industry segment, Regis Technologies has ... IND Filing” on December 4th at 11am EST. , Federal law does not allow ...
(Date:11/30/2015)... ... November 30, 2015 , ... Vasont ... their Vasont Universal Integrator (VUI) extension unites with Syncro Soft’s latest software update, ... as a continuous process with the latest release of oXygen® XML editor and ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... HANOVER, N.J. , Nov. 30, 2015  Novartis ... portfolio at the 57 th American Society of ... leukemias, lymphomas and myelomas as well as supportive care, ... in addition to personalized cell therapies. The ASH Annual ... Orlando, Florida . Novartis Oncology . ...
(Date:11/30/2015)... , Belgium , Nov. 30, 2015 ... sciences company focused on developing blood-based diagnostic tests for a ... the Company will present at the LD Micro Conference, which ... Los Angeles, CA. Attending from VolitionRx will be ... Scott Powell , Vice President of Investor Relations. ...
(Date:11/30/2015)... , Nov. 30, 2015  Precision Image ... services, is pleased to announce a dramatic expansion ... imaging services. Building on its ISO-9001:2008 certification for ... implemented comprehensive Core Lab protocols and procedures. This ... of research activities.  Their Core Lab services include ...
Breaking Medicine Technology: